Clinical Trial 551

Birmingham, AL 35203


Summary:

Dosing of approved drug Mesalamine in children and adolescent patients with ulcerative colitis.


Qualified Participants Must:

• Male or Female between the ages of 5 and 17yrs,inclusive
• mildly or moderately active ulcerative colitis
• able to swallow Asacol tablets(400mg)
• body wt no less than 10kg and no more than 90kg(between 22 and 198 lbs)


Qualified Participants May Receive:

Compensated appropriately for time and travel.


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.